Unknown

Dataset Information

0

Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs.


ABSTRACT: Zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) have been successfully used to knock out endogenous genes in stem cell research. However, the deficiencies of current gene-based delivery systems may hamper the clinical application of these nucleases. A new delivery method that can improve the utility of these nucleases is needed.In this study, we utilized a cell-penetrating peptide-based system for ZFN and TALEN delivery. Functional TAT-ZFN and TAT-TALEN proteins were generated by fusing the cell-penetrating TAT peptide to ZFN and TALEN, respectively. However, TAT-ZFN was difficult to purify in quantities sufficient for analysis in cell culture. Purified TAT-TALEN was able to penetrate cells and disrupt the gene encoding endogenous human chemokine (C-C motif) receptor 5 (CCR5, a co-receptor for HIV-1 entry into cells). Hypothermic treatment greatly enhanced the TAT-TALEN-mediated gene disruption efficiency. A 5% modification rate was observed in human induced pluripotent stem cells (hiPSCs) treated with TAT-TALEN as measured by the Surveyor assay.TAT-TALEN protein-mediated gene disruption was applicable in hiPSCs and represents a promising technique for gene knockout in stem cells. This new technique may advance the clinical application of TALEN technology.

SUBMITTER: Ru R 

PROVIDER: S-EPMC4230761 | biostudies-other | 2013

REPOSITORIES: biostudies-other

altmetric image

Publications

Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs.

Ru Renli R   Yao Yongchao Y   Yu Songlin S   Yin Benpeng B   Xu Wanwan W   Zhao Siting S   Qin Li L   Chen Xiaoping X  

Cell regeneration (London, England) 20130618 1


<h4>Background</h4>Zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) have been successfully used to knock out endogenous genes in stem cell research. However, the deficiencies of current gene-based delivery systems may hamper the clinical application of these nucleases. A new delivery method that can improve the utility of these nucleases is needed.<h4>Results</h4>In this study, we utilized a cell-penetrating peptide-based system for ZFN and TALEN delivery  ...[more]

Similar Datasets

| S-EPMC7816568 | biostudies-literature
| S-EPMC5889534 | biostudies-literature
| S-EPMC6894808 | biostudies-literature
| S-EPMC3666730 | biostudies-literature
| S-EPMC3680803 | biostudies-other
| S-EPMC3677304 | biostudies-literature
| S-EPMC9327527 | biostudies-literature
| S-EPMC3100451 | biostudies-literature
| S-EPMC7298853 | biostudies-literature
| S-EPMC3785731 | biostudies-literature